John K. Clarke
@johnkclarke
Director
Building aTYR PHARMA INC as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Vividion Therapeutics, Inc. was founded in 2013 and has no closure on record.
Named alongside
- Akkaraju C. SrinivasDirector
- Amir C. NashatDirector
- Amir H. Nashat, Sc.D.Director
- David C. WeinerExecutive Officer
- Ed C. PenhoetDirector
- Frederic C. ChereauExecutive Officer
- James C. BlairDirector
- Jeffrey S. HatfieldDirector
- Elizabeth K. SpauldingDirector
- Elizabeth T. SpauldingDirector
- JOHN DOERRDirector
- John K. ParkExecutive Officer
- John ParkExecutive Officer
- Kent K. MarquardtDirector
- Kent MarquardtDirector
- Kent T. MarquardtDirector
At Ivenix, Inc.
- Carolyn MalleckExecutive Officer
- Carolyn M. MalleckExecutive Officer
- Colin J. FosterDirector
- Darrell CrateDirector
- Darrell J. CrateDirector
- George GrayExecutive Officer
- George W. GrayExecutive Officer
- Jesse AmbrosinaExecutive Officer
At Vividion Therapeutics, Inc.
- Benjamin K. CravattDirector
- Benjamin L. CravattDirector
Contribution
John's ideas, decisions and failures appear here once this profile is claimed.
Companies
- aTYR PHARMA INCBiological Products, (No Diagnostic Substances); listed on Nasdaq as ATYR; filing with the SEC since 2005Director · Biotechnology · SAN DIEGO, United States
- Ivenix, Inc.formerly Fluidnet CORP; filing with the SEC since 2007Director · Biotechnology · AMESBURY, United States
- Vividion Therapeutics, Inc.Pharmaceutical Preparations; filing with the SEC since 2016Executive Officer, Director · Biotechnology · PRINCETON, United States · Founded 2013
- Cardinal Analytx, Inc.formerly Cardinal Analytx, Inc.; filing with the SEC since 2017Director · Other Technology · SAN FRANCISCO, United States · Founded 2013